Argan
118 hedge funds and large institutions have $378M invested in Argan in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 57 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
20% more call options, than puts
Call options by funds: $465K | Put options by funds: $387K
4% more capital invested
Capital invested by funds: $365M → $378M (+$13.1M)
1% more funds holding
Funds holding: 117 → 118 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.32% less ownership
Funds ownership: 81.97% → 81.65% (-0.32%)
46% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 57
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.3M |
| 2 |
Goldman Sachs
New York
|
-$2.74M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.28M |
| 4 |
JGUA
John G. Ullman & Associates
Corning,
New York
|
-$1.9M |
| 5 |
Renaissance Technologies
New York
|
-$1.07M |
AGX Hedge Fund Activity: Q4 2022 in Review
118 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Argan (AGX) for Q4 2022, worth a combined $378M — up 3.6% from $365M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new AGX positions and 8 closed out — a net gain of 2 holders — while 31 added to existing stakes and 57 trimmed.
The largest buyer was Royce & Associates, opening a new position worth an estimated $3.9M. The largest seller was Fidelity Investments, cutting an estimated $7.3M.
- 118 institutional investors held Argan (AGX) as of Q4 2022, up from 117 in Q3 2022.
- Funds reported $378M of Argan stock for Q4 2022, up 3.6% quarter-over-quarter.
- 10 funds opened new Argan positions in Q4 2022 and 8 closed out, a net change of +2 holders.
- The largest Argan buyer in Q4 2022 was Royce & Associates, an estimated $3.9M added.
- The largest Argan seller in Q4 2022 was Fidelity Investments, an estimated $7.3M sold.
Based on aggregated 13F filings for Q4 2022.